Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity.
Saved in:
| Title: | Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity. |
|---|---|
| Authors: | Vicente MM; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.; Graduate Program in Areas of Basic and Applied Biology (GABBA), ICBAS, University of Porto, Porto, Portugal.; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal., Alves I; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal., Gaifem J; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal., Rodrigues CS; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal., Fernandes Â; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal., Dias AM; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal., Štambuk J; Genos Glycoscience Research Laboratory, Zagreb, Croatia., Petrović T; Genos Glycoscience Research Laboratory, Zagreb, Croatia., Oliveira P; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal., Ferreira-da-Silva F; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.; Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal., Soares A; Internal Medicine Department, Hospital Beatriz Ângelo, Loures, Portugal., Seixas N; Department of Infectious Diseases, Centro Hospitalar Vila Nova de Gaia/Espinho, Gaia, Portugal., Teixeira T; Department of Infectious Diseases, Centro Hospitalar Vila Nova de Gaia/Espinho, Gaia, Portugal., Malheiro L; Department of Clinical Pathology, Centro Hospitalar Vila Nova de Gaia/Espinho, Gaia, Portugal., Abreu MM; Department of Infectious Diseases, Centro Hospitalar Universitário do Porto, Porto, Portugal., Lauc G; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia., Sarmento E Castro R; Department of Infectious Diseases, Centro Hospitalar Universitário do Porto, Porto, Portugal., Pinho SS; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal. |
| Source: | European journal of immunology [Eur J Immunol] 2022 Jun; Vol. 52 (6), pp. 946-957. Date of Electronic Publication: 2022 Apr 04. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1521-4141 |
|---|---|
| DOI: | 10.1002/eji.202149491 |
